Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of imidazolidin in the preparation of medicines for preventing and treating bmnpv-infected silkworm cells

A technology of imidazolone and silkworm, which is applied in the application field of imidazolone in the preparation of medicine for preventing and controlling BmNPV infection of silkworm cells

Active Publication Date: 2018-12-14
JIANGSU UNIV OF SCI & TECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the process of screening compounds for the treatment of silkworm blood type pus disease, the inventors found that imidazolidin has a significant inhibitory effect on BmNPV. At present, there are no patents and literature reports on the application of imidazolidin to the prevention and treatment of viruses and BmNPV

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of imidazolidin in the preparation of medicines for preventing and treating bmnpv-infected silkworm cells
  • Application of imidazolidin in the preparation of medicines for preventing and treating bmnpv-infected silkworm cells
  • Application of imidazolidin in the preparation of medicines for preventing and treating bmnpv-infected silkworm cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] 1. Construction of BmNPV carrying egfp reporter gene

[0021] The egfp fragment was cloned into the BamHI (Takara) and XhoI (Takara) sites of pFastBac1 (Invitrogen), and the donor plasmid pFastBac-egfp was constructed, and BmBac-egfp was obtained by transposition ( figure 1 ), after the BmBac-egfp DNA was transfected into BmN (bombyx mori ovary cells) cells, the expression of green fluorescence could be observed under a fluorescent microscope. The cell supernatant was used to infect BmN cells, and the virus was harvested 72 hours after infection, and the virus titer was determined by the terminal dilution method, and the virus was stored in a refrigerator at 4°C in the dark.

[0022] 2. Inoculation of cells and preparation of storage solution of imidazolidin

[0023] (1) Inoculate about 10 cells in a 35mm cell culture dish (Corning) respectively. 5 Add 2 mL of 10% FBS TC100 insect cell culture medium to each cell dish of BmN cells.

[0024] (2) Culture at 27°C for ab...

Embodiment 2

[0033] When the final concentration of imidazolidin is 1 μg / mL, the prevention and treatment of BmNPV infection carrying the egfp reporter gene:

[0034] (1) Take 10 of each inoculation 5 For 3 culture dishes of cells, add 2 mL of TC100 insect cell culture medium with 10% FBS to each dish. The old medium was removed, and 2 μL of 10 mg / mL imidazolidin stock solution and 2 mL of 10% FBS TC100 medium were added respectively, incubated at 27° C. for 30 min, and then BmBac-egfp virus with MOI=10 was added.

[0035] (2) After 72 hours, place 3 dishes in a fluorescent inverted microscope to observe the expression of green fluorescent protein, see figure 2 (T1).

[0036] (3) Take 10 μL of cell culture solution, and measure the virus titer by terminal dilution method.

[0037] The results showed that when cells were treated with 1 μg / mL imidaclomidone, the cells infected by BmNPV did not produce fluorescence, and completely inhibited, and the virus titer was 0 ( image 3 T1).

Embodiment 3

[0039] When the final concentration of imidazolidin is 0.25 μg / mL, the prevention and treatment of BmNPV infection carrying the egfp reporter gene:

[0040] (1) Take 10 of each inoculation 5 For 3 culture dishes of cells, add 2 mL of TC100 insect cell culture medium with 10% FBS to each dish. The old medium was removed, and 0.5 μL of 10 mg / mL imidazolidin stock solution and 2 mL of 10% FBS TC100 medium were added respectively, incubated at 27° C. for 30 min, and then BmBac-egfp virus with MOI=10 was added.

[0041] (2) After 72 hours, place 3 dishes in a fluorescent inverted microscope to observe the expression of green fluorescent protein, see figure 2 (T0.25).

[0042] (3) Take 10 μL of cell culture solution, and measure the virus titer by terminal dilution method.

[0043] The results showed that when cells were treated with 0.25 μg / mL imidazolidin, the fluorescence of BmNPV-infected cells was significantly reduced compared with the control, and the virus titer Log 10 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The application of imidazolidin in the preparation of drugs for the prevention and treatment of silkworm cells infected by BmNPV belongs to the field of molecular biology and virology. When the final concentration of imidazolidin is above 1 μg / mL, it can completely inhibit the replication of BmNPV, and it can completely inhibit the replication of BmNPV in BmNPV. After infection, it can continue to inhibit the replication of BmNPV and has a therapeutic effect. The invention can be used for the research, development and production of medicines for preventing and treating silkworm blood type pus disease, and has the value of application and popularization.

Description

technical field [0001] The invention belongs to the field of molecular biology and virology, and relates to the application of imidaclofen in the preparation of medicines for preventing and treating silkworm cells infected by BmNPV. Background technique [0002] Bombyx mori blood type pus disease is the most serious disease among the three major virus diseases in sericulture. It is highly contagious and has occurred more commonly in sericulture production in recent years. production situation. The cause of disease of silkworm blood type pus disease is silkworm nucleopolyhedrovirus (Bombyx mori nucleopolyhedrovirus, BmNPV), this virus belongs to baculoviridae, nucleopolyhedrovirus genus, is a kind of virus with envelope, double-stranded DNA, it During the virus replication process, two kinds of virions will be formed, namely inclusion body-derived virions and budding virions. The former enters the midgut cells of silkworm midgut with food, and the infected midgut cells will ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4166A61P31/20
CPCA61K31/4166
Inventor 唐旭东沈中元徐莉于洁
Owner JIANGSU UNIV OF SCI & TECH